WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
2025 US-Japan Healthcare Innovation Conference
Affiliated Programs
Tuesday, September 16, 2025 - Friday, September 19, 2025

Tokyo/Osaka, Japan

Wilson Sonsini is pleased to sponsor the 2025 US-Japan Healthcare Innovation Conference.

Originally launched in 2014, the US-Japan Healthcare Innovation Conference is dedicated to driving innovation in the healthcare sectors of the US and Japan by bringing together leaders in the life sciences industry, government, and academia to discuss the latest trends and topics that are changing the face of healthcare. 

This year’s theme is: How AI and Science are Driving the Future of Medicine: Advancing US-Japan Healthcare Collaboration From Kansai to the World.

This event draws hundreds of attendees from the private, public, and academic sectors in Japan. Past attendees have included representatives from companies such as CMIC, Hoya, Kaneka, Mitsubishi Corp., NIPRO, Otsuka, Ricoh, Sumitomo, Takeda, Terumo, UTEC, and many more, as well as government agencies including AMED. JETRO, MHLW, METI, and others.

On September 16th at 12:50pm in Tokyo, partner Seth Flaum will participate in the panel discussion, Impact of AI on Life Science Innovation. At 3:50pm on September 16th in Tokyo, partner Elton Satusky will moderate the panel session, Building Global Enterprises in Life Sciences – US and Japan Approaches. On September 19th in Osaka, at 10:15am, partner Seth Flaum will participate in the panel discussion, Impact of AI on Life Science Innovation. At 2:30pm on September 19th in Osaka, partner Elton Satusky will moderate the panel session, Building Global Enterprises in Life Sciences – US and Japan Approaches.

The conference is organized by the US-Japan Healthcare Connection (www.usjhealthcare.org) a collaborative initiative of the Japan Society of Northern California (JSNC) and US-Japan Medtech Frontiers (USJMF), two organizations dedicated to promoting cooperation and understanding between the US and Japan. Our partners and co-organizers for this year’s event are LINK-J Japan, and Osaka University. 

To learn more about the event scheduled sessions, please visit the event website.

Contacts

Norilyn Ingram

ningram@wsgr.com

Presenters

Elton Satusky
Partner
Palo Alto

Elton specializes in public and private corporate finance and corporate law and governance. He also has considerable M&A and venture capital experience.

View Profile
Seth Flaum
Partner
New York

Seth Flaum is a partner in the New York office of Wilson Sonsini Goodrich & Rosati, where he is a member of the technology transactions practice. With more than 25 years of broad transactional experience, he represents life sciences companies in a wide range of strategic transactions and corporate matters.

View Profile
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.